Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Invitro Maturation of Oocytes for Patients With Polycystic Ovaries

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2008 by Assaf-Harofeh Medical Center.
Recruitment status was:  Not yet recruiting
Information provided by:
Assaf-Harofeh Medical Center Identifier:
First received: March 3, 2008
Last updated: March 7, 2008
Last verified: March 2008
In vitro maturation of oocytes after minimal gonadotropin stimulation in patients with polycystic ovaries, to prevent cases of ovarian hyperstimulation.

Condition Intervention
Polycystic Ovaries
Procedure: in vitro matuartion of oocytes

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: In Vitro Maturation of Oocytes for Patients With Polycystic Ovaries

Resource links provided by NLM:

Further study details as provided by Assaf-Harofeh Medical Center:

Primary Outcome Measures:
  • maturation rate, [ Time Frame: 18 months ]

Secondary Outcome Measures:
  • Fertilization rate, pregnancy rate [ Time Frame: 18 months ]

Estimated Enrollment: 30
Study Start Date: April 2008
Estimated Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Group I
patients with PCO undergoing in vitro maturation and subsequently IVF and embryo transfer
Procedure: in vitro matuartion of oocytes
in vitro maturation of (immature) oocytes


Ages Eligible for Study:   18 Years to 39 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Polycystic ovaries
  • Needing IVF for fertility treatment

Exclusion Criteria:

  • Age above 39
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00631982

Contact: Raphael Ron - El, MD +972-8-9779005

IVF and Infertility Unit, Assaf Harofeh Medical Center Not yet recruiting
Zerifin, Israel, 70300
Contact: Raphael Ron-El, MD    +972-8-9779005      
Principal Investigator: Raphael Ron - El, MD         
Sponsors and Collaborators
Assaf-Harofeh Medical Center
  More Information

Responsible Party: IVF and Infertility Unit, Assaf Harofeh Medical Center, Zerifin Israel, Assaf Harofeh Medical Center, Zerifin Israel Identifier: NCT00631982     History of Changes
Other Study ID Numbers: 22/08
Study First Received: March 3, 2008
Last Updated: March 7, 2008

Keywords provided by Assaf-Harofeh Medical Center:
in vitro maturation oocytes

Additional relevant MeSH terms:
Polycystic Ovary Syndrome
Genital Diseases, Male
Genital Diseases, Female
Ovarian Cysts
Ovarian Diseases
Adnexal Diseases
Gonadal Disorders
Endocrine System Diseases processed this record on May 25, 2017